US4432977A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for dilating the smooth muscles of the upper urinary tract
Assignee: WILLIAM P POYTHRESS & Co
•
Filing: 1982-08-27
•
Granted: 1984-02-21
•
Expires: 2002-08-27
Abstract
Abstract Dilation of smooth muscles of the upper urinary tract with a di-N-substituted aminoethyl ester of diphenylthioacetic acid.
Inventors
- 👤 William M. Davis
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-26 18:04
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K31/445; A61K31/21; A61K31/265; A61K31/28; A61K31/285; A61K31/535; A61P; A61P13/00; A61P13/02; A61P15/00
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
58 words
A method for dilating the smooth muscles of the upper urinary tract comprising administering to a patient requiring such treatment an effective amount of a di-N-substituted aminoethyl ester of diphenylthioacetic acid having the formula: ##STR4## in which R represents a disubstituted amino radical of the group consisting of the diethylamino group, the morpholino group and the piperidino group.
Claim 2
Independent Claim
58 words
A method for dilating the smooth muscles of the upper urinary tract comprising administering to a patient requiring such treatment an effective amount of a di-N-substituted aminoethyl ester of diphenylthioacetic acid having the formula: ##STR4## in which R represents a disubstituted amino radical of the group consisting of the diethylamino group, the morpholino group and the piperidino group.
Claim 3
Dependent Claim
33 words
The method as described in claim 1, wherein the di-N-substituted aminoethyl ester of diphenylthioacetic acid is administered in a dosage of from about 0.7 to about 11.4 mg per kiligram of body weight.
Claim 4
Dependent Claim
34 words
The method as described in claim 1, wherein the di-N-substituted aminoethyl ester of diphenylthioacetic acid is administered in a preferred dosage of from about 1.4 to about 5.7 mg per kiligram of body weight.
Claim 5
Dependent Claim
35 words
The method as described in claim 1, wherein the di-N-substituted aminoethyl ester of diphenylthioacetic acid is administered in a more preferred dosage of from about 2.8 to about 5.7 mg per kiligram of body weight.
Claim 6
Dependent Claim
22 words
The method as described in claim 2, wherein the di-N-substituted aminoethyl ester of diphenylthioacetic acid is combined with a pharmaceutically accepted carrier.
Claim 7
Independent Claim
53 words
A method of treating a patient passing a kidney stone comprising administering to the patient an effective amount of a di-N-substituted aminoethyl ester of diphenylthioacetic acid of the formula: ##STR5## in which R represents a disubstituted amino radical of the group consisting of the diethylamino group, the morpholino group and the piperidino group.
Claim 8
Independent Claim
53 words
A method of treating a patient passing a kidney stone comprising administering to the patient an effective amount of a di-N-substituted aminoethyl ester of diphenylthioacetic acid of the formula: ##STR5## in which R represents a disubstituted amino radical of the group consisting of the diethylamino group, the morpholino group and the piperidino group.
Claim 9
Dependent Claim
35 words
The method as described in claim 6, wherein the di-N-substituted aminoethyl ester of diphenyl-thioacetic acid is administered in a dosage in the range from about 0.7 to about 11.4 mg per kiligram of body weight.
Claim 10
Dependent Claim
36 words
The method as described in claim 6, wherein the di-N-substituted aminoethyl ester of diphenylthioacetic acid is administered in a preferred dosage in the range from about 1.4 to about 5.7 mg per kiligram of body weight.
Claim 11
Dependent Claim
37 words
The method as described in claim 6, wherein the di-N-substituted aminoethyl ester of diphenylthioacetic acid is administered in a more preferred dosage in the range from about 2.8 to about 5.7 mg per kiligram of body weight.
Claim 12
Dependent Claim
22 words
The method as described in claim 7, wherein the di-N-substituted aminoethyl ester of diphenylthioacetic acid is combined with a pharmaceutically acceptable carrier.
Claim 13
Independent Claim
81 words
A method for dilating the smooth muscles of the upper urinary tract comprising directly effecting the muscle fibers and the pacemaker of contractility of the renal pelvis and ureter to allow the passage of an obstructing, intraluminal foreign body, by administering to a patient requiring such treatment a di-N-substituted aminoethyl ester of diphenylthioacetic acid having the formula: ##STR6## in which R represents a disubstituted amino radical of the group consisting of the diethylamino group, the morpholino group and the piperidino group.
Claim 14
Independent Claim
81 words
A method for dilating the smooth muscles of the upper urinary tract comprising directly effecting the muscle fibers and the pacemaker of contractility of the renal pelvis and ureter to allow the passage of an obstructing, intraluminal foreign body, by administering to a patient requiring such treatment a di-N-substituted aminoethyl ester of diphenylthioacetic acid having the formula: ##STR6## in which R represents a disubstituted amino radical of the group consisting of the diethylamino group, the morpholino group and the piperidino group.
Claim 15
Independent Claim
76 words
A method of treating a patient having an upper urinary tract which is at least partially obstructed by a renal calculus comprising altering the renal pelvis and ureteral contractile pacemaker to allow ureteral dilitation and calculus passage by administering to the patient a di-N-substituted aminoethyl ester of diphenylthioacetic acid of the formula: ##STR7## in which R represents a disubstituted amino radical of the group consisting of the diethylamino group, the morpholino group and the piperidino group.
Claim 16
Independent Claim
76 words
A method of treating a patient having an upper urinary tract which is at least partially obstructed by a renal calculus comprising altering the renal pelvis and ureteral contractile pacemaker to allow ureteral dilitation and calculus passage by administering to the patient a di-N-substituted aminoethyl ester of diphenylthioacetic acid of the formula: ##STR7## in which R represents a disubstituted amino radical of the group consisting of the diethylamino group, the morpholino group and the piperidino group.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-02-20 | 1987-08-22 | 1988-02-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-02-20 | 1991-08-22 | 1992-02-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-02-20 | 1995-08-22 | 1996-02-21 | $7700.00 | Window Closed / Lapsed |